Recent data from 2023 reveals that Russia leads with a 98.9% share of corresponding/leading authorship in scientific publications in endocrinology, diabetes, and metabolism, followed closely by China and South Korea. Notably, countries like Iceland and Luxembourg display significantly lower shares, suggesting potential collaborative publications with foreign researchers.
Future trends may include emerging markets like India and Brazil gaining prominence, while mature markets like the US and UK could experience increased collaboration. Enhanced international cooperation might drive a balancing of shares, particularly in countries with current low authorship percentages.
Top countries in Share of Corresponding/Leading Author in Scientific Publications in Endocrinology, Diabetes and Metabolism by Country
| # | 10 Countries | Percent | Last Year | |
|---|---|---|---|---|
| 1 | 1 Russia | 98.9 | 2023 | View data |
| 2 | 2 China | 98.82 | 2023 | View data |
| 3 | 3 South Korea | 98.56 | 2023 | View data |
| 4 | 4 Ukraine | 97.89 | 2021 | View data |
| 5 | 5 Japan | 97.65 | 2023 | View data |
| 6 | 6 Indonesia | 96.06 | 2023 | View data |
| 7 | 7 Kazakhstan | 96.05 | 2023 | View data |
| 8 | 8 Romania | 95.97 | 2023 | View data |
| 9 | 9 Brazil | 95.85 | 2023 | View data |
| 10 | 10 Malta | 95.82 | 2023 | View data |
